Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00036647
Status:
COMPLETED
Last Update Posted:
2018-01-10
First Post:
2002-05-13
Brief Title:
OSI-774 Tarceva in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
OSI Pharmaceuticals
Organization:
Astellas Pharma Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2004-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-01-30
Completion Date Type:
ACTUAL
First Submit Date:
2002-05-13
First Submit QC Date:
May 13 2002
Study First Post Date:
2002-05-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-08
Last Update Post Date:
2018-01-10
Last Update Post Date Type:
ACTUAL